Cargando…
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study
Although changes in serum sclerostin levels at 12 months after infusion of zoledronic acid have been reported, the changes in sclerostin levels at earlier time points are poorly understood. We reanalyzed the study data of a previous phase 1 pharmacokinetic study and investigated the correlation betw...
Autores principales: | Kuroda, Tatsuhiko, Shiraki, Masataka, Nakamura, Toshitaka, Suzuki, Hiroaki, Hiraishi, Kazuki, Sugimoto, Toshitsugu, Tanaka, Satoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732852/ https://www.ncbi.nlm.nih.gov/pubmed/34427705 http://dx.doi.org/10.1007/s00223-021-00900-w |
Ejemplares similares
-
Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study
por: Shiraki, Masataka, et al.
Publicado: (2021) -
Renal Phosphate Reabsorption is Correlated with the Increase in Lumbar Bone Mineral Density in Patients Receiving Once-Weekly Teriparatide
por: Takeuchi, Yasuhiro, et al.
Publicado: (2015) -
Levels of serum sclerostin, FGF-23, and intact parathyroid hormone in postmenopausal women treated with calcitriol
por: Cheng, Qun, et al.
Publicado: (2018) -
New simulation model for bone formation markers in osteoporosis patients treated with once-weekly teriparatide
por: Tanaka, Sakae, et al.
Publicado: (2014) -
Parathyroid carcinoma survival: improvements in the era of intact parathyroid hormone monitoring?
por: Allen, Miya E., et al.
Publicado: (2013)